NEU neuren pharmaceuticals limited

Ann: NEU confirms primary endpoints for Phase 3 trial in PMS, page-27

  1. 1,383 Posts.
    lightbulb Created with Sketch. 445
    With NEU share price is significantly undervalued with P/E ratio of 9.12 compared to SIG trading with a P/E of 115, which one has more potential to grow x3 - x4 times from here. The probability of receiving the Take Over offer is closing day by day with today's announcement.

    I hope the management do not accept an offer which will disappoint its shareholders. I have seen such a disgruntle with MYX takeover where majority of retail holders were disappointed. This is absolute BUY now but DYOR before any buy and sell decision. My BUY AND HOLD position won't change until next year.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.62
Change
0.140(0.85%)
Mkt cap ! $2.093B
Open High Low Value Volume
$16.48 $16.77 $16.28 $1.912M 115.5K

Buyers (Bids)

No. Vol. Price($)
5 44 $16.62
 

Sellers (Offers)

Price($) Vol. No.
$16.63 67 5
View Market Depth
Last trade - 13.49pm 28/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.